OQS
DMTK

Occudo Quantitative Strategies’s DermTech, Inc. Common Stock DMTK Stock Holding History

Occudo Quantitative Strategies’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-43,214
Closed -$76.5K – 1271
2022
Q4 		$76.5K Buy
+43,214
New +$115K 0.01% 867

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Occudo Quantitative Strategies's DMTK Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2023, closing a stake of 43,214 shares — an estimated $76.5K sold.

Occudo Quantitative Strategies first reported a position in DMTK in Q4 2022 and held it in 1 quarter. The position peaked at $76.5K in Q4 2022. 99 funds tracked by Wall St. Rank hold DMTK as of Q1 2023.

  • Occudo Quantitative Strategies reported no remaining DermTech, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 43,214 DermTech, Inc. Common Stock shares in Q1 2023, an estimated $76.5K.
  • Occudo Quantitative Strategies first reported a position in DermTech, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's DermTech, Inc. Common Stock position peaked at $76.5K in Q4 2022.
  • 99 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.